Patents by Inventor Kimberly Ashely SNYDER

Kimberly Ashely SNYDER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-podocalyxin antibodies and methods of using the same
    Patent number: 11390673
    Abstract: The present invention is directed to compositions of matter useful for the treatment of cancer in mammals and to methods of using those compositions of matter for the same. Antibodies specific for podocalyxin designated Ab1 and 3G2 are disclosed, as is the use of said antibodies for the inhibition of growth of a tumor that expresses podocalyxin, and the use of said anti bodies for targeting tumour endothelial cells that express podocalyxin.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: July 19, 2022
    Inventors: John Stephen Babcook, Kelly Marshall McNagny, Calvin D. Roskelley, Bradley John Hedberg, Kimberly Ashely Snyder, Michael R. Hughes
  • ANTI-PODOCALYXIN ANTIBODIES AND METHODS OF USING THE SAME
    Publication number: 20190367606
    Abstract: The present invention is directed to compositions of matter useful for the treatment of cancer in mammals and to methods of using those compositions of matter for the same. Antibodies specific for podocalyxin designated Ab1 and 3G2 are disclosed, as is the use of said antibodies for the inhibition of growth of a tumor that expresses podocalyxin, and the use of said antibodies for targeting tumour endothelial cells that express podocalyxin.
    Type: Application
    Filed: August 12, 2019
    Publication date: December 5, 2019
    Inventors: John Stephen BABCOOK, Kelly Marshall MCNAGNY, Calvin D. ROSKELLEY, Bradley John HEDBERG, Kimberly Ashely SNYDER, Michael R. HUGHES
  • ANTI-PODOCALYXIN ANTIBODIES AND METHODS OF USING THE SAME
    Publication number: 20160264663
    Abstract: The present invention is directed to compositions of matter useful for the treatment of cancer in mammals and to methods of using those compositions of matter for the same. Antibodies specific for podocalyxin designated Ab1 and 3G2 are disclosed, as is the use of said antibodies for the inhibition of growth of a tumor that expresses podocalyxin, and the use of said antibodies for targeting tumour endothelial cells that express podocalyxin.
    Type: Application
    Filed: October 21, 2014
    Publication date: September 15, 2016
    Inventors: John Stephen BABCOOK, Kelly Marshall MCNAGNY, Calvin D. ROSKELLEY, Bradley John HEDBERG, Kimberly Ashely SNYDER, Michael R. HUGHES